Damien Alan Perriman
CIK 2096714 · View on SEC EDGAR ↗
First SEC filing: April 8, 2026 · Latest: April 8, 2026
On this page
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | EXOZ | A | 8,887 | $8.44 | $75,006 | 0 Direct | — | Acquired | -20.6% (price as of 2026-08-24) |
| April 1, 2026 | EXOZ | A | 62,759 | — | — | 62,759 Direct | — | Acquired | (price as of 2026-08-24) |
| April 1, 2026 | EXOZ | A | 146,437 | — | — | 146,437 Direct | — | Acquired | (price as of 2026-08-24) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| April 1, 2026 | EXOZ | Stock Option for Common Stock [F2] | Common Stock (146,437) | $9.49 | April 12, 2033 | 146,437 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).